TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand
- PMID: 16275760
- PMCID: PMC2213234
- DOI: 10.1084/jem.20051135
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand
Abstract
We recently showed that dendritic cells (DCs) activated by thymic stromal lymphopoietin (TSLP) prime naive CD4(+) T cells to differentiate into T helper type 2 (Th2) cells that produced high amounts of tumor necrosis factor-alpha (TNF-alpha), but no interleukin (IL)-10. Here we report that TSLP induced human DCs to express OX40 ligand (OX40L) but not IL-12. TSLP-induced OX40L on DCs was required for triggering naive CD4(+) T cells to produce IL-4, -5, and -13. We further revealed the following three novel functional properties of OX40L: (a) OX40L selectively promoted TNF-alpha, but inhibited IL-10 production in developing Th2 cells; (b) OX40L lost the ability to polarize Th2 cells in the presence of IL-12; and (c) OX40L exacerbated IL-12-induced Th1 cell inflammation by promoting TNF-alpha, while inhibiting IL-10. We conclude that OX40L on TSLP-activated DCs triggers Th2 cell polarization in the absence of IL-12, and propose that OX40L can switch IL-10-producing regulatory Th cell responses into TNF-alpha-producing inflammatory Th cell responses.
Figures
Similar articles
-
Exosomes from Thymic Stromal Lymphopoietin-Activated Dendritic Cells Promote Th2 Differentiation through the OX40 Ligand.Pathobiology. 2019;86(2-3):111-117. doi: 10.1159/000493013. Epub 2018 Nov 8. Pathobiology. 2019. PMID: 30408778
-
Amygdalin Improves Allergic Asthma via the Thymic Stromal Lymphopoietin-dendritic Cell-OX40 Ligand Axis in a Mouse Model.Iran J Allergy Asthma Immunol. 2023 Oct 29;22(5):430-439. doi: 10.18502/ijaai.v22i5.13993. Iran J Allergy Asthma Immunol. 2023. PMID: 38085145
-
Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs.J Immunol. 2004 Apr 1;172(7):4253-9. doi: 10.4049/jimmunol.172.7.4253. J Immunol. 2004. PMID: 15034038
-
Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses.Clin Exp Allergy. 2009 Jun;39(6):798-806. doi: 10.1111/j.1365-2222.2009.03241.x. Epub 2009 Apr 7. Clin Exp Allergy. 2009. PMID: 19400908 Free PMC article. Review.
-
Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation.J Allergy Clin Immunol. 2007 Aug;120(2):238-44; quiz 245-6. doi: 10.1016/j.jaci.2007.06.004. J Allergy Clin Immunol. 2007. PMID: 17666213 Review.
Cited by
-
Quantitative Phosphoproteomic Analysis Reveals Dendritic Cell- Specific STAT Signaling After α2-3-Linked Sialic Acid Ligand Binding.Front Immunol. 2021 Apr 22;12:673454. doi: 10.3389/fimmu.2021.673454. eCollection 2021. Front Immunol. 2021. PMID: 33968084 Free PMC article.
-
The transcription factor STAT5 is critical in dendritic cells for the development of TH2 but not TH1 responses.Nat Immunol. 2013 Apr;14(4):364-71. doi: 10.1038/ni.2541. Epub 2013 Feb 24. Nat Immunol. 2013. PMID: 23435120 Free PMC article.
-
Routinely Used and Emerging Diagnostic and Immunotherapeutic Approaches for Wheat Allergy.Biomedicines. 2024 Jul 12;12(7):1549. doi: 10.3390/biomedicines12071549. Biomedicines. 2024. PMID: 39062122 Free PMC article. Review.
-
Novel identified receptors on mast cells.Front Immunol. 2012 Aug 2;3:238. doi: 10.3389/fimmu.2012.00238. eCollection 2012. Front Immunol. 2012. PMID: 22876248 Free PMC article.
-
Applications and mechanisms of immunotherapy in allergic rhinitis and asthma.Ther Adv Respir Dis. 2017 Jan;11(1):73-86. doi: 10.1177/1753465816669662. Epub 2016 Sep 27. Ther Adv Respir Dis. 2017. PMID: 27678500 Free PMC article. Review.
References
-
- O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:275–283. - PubMed
-
- Mosmann, T.R., and R.L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145–173. - PubMed
-
- Borish, L., A. Aarons, J. Rumbyrt, P. Cvietusa, J. Negri, and S. Wenzel. 1996. Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol. 97:1288–1296. - PubMed
-
- Pretolani, M., and M. Goldman. 1997. IL-10: a potential therapy for allergic inflammation? Immunol. Today. 18:277–280. - PubMed
-
- Barnes, P.J. 2001. IL-10: a key regulator of allergic disease. Clin. Exp. Allergy. 31:667–669. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
